News
12hOpinion
MedPage Today on MSNRemoving Restraints: Reclaiming Patient Dignity in Delirium CareResearch supports the management of delirium with tools other than medication. Hand massage has been shown to reduce stress ...
Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.
Their most common features were agitation, irritability, pressured speech, and flight of ideas. Other researchers identified hypomanic features in 97 bipolar-II and 64 unipolar patients with major ...
Dancing is known to lift the spirit, and a new study shows that Alzheimer's disease patients respond to the rhythmic moves as well. Dance classes eased agitation in a small group of people with ...
Agitated patients are often prescribed antipsychotic medications and sedatives off-label, but this can pose a risk to the ...
Agitated Solutions receives IND application clearance from US FDA to begin phase 3 clinical trial for its novel contrast agent, ASI-02: St. Paul, Minn. Friday, April 11, 2025, 15: ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results